Trial treatment consists of a loading dose of tranexamic acid ( 1 g by intravenous injection ) or placebo ( sodium chloride 0.9 % ) given as soon as possible after randomisation , followed by an intravenous infusion of 3 g tranexamic acid or placebo ( sodium chloride 0.9 % ) over 24 hours .